Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age

Vaccine

Volumn 33, Issue 5, 2015, Pages 628-634

  Nunes, Marta C ^a   Jones, Stephanie A ^a   Groome, Michelle J ^a   Kuwanda, Locadiah ^a   Van Niekerk, Nadia ^a   von Gottberg, Anne ^a,b   de Gouveia, Linda ^a,b   Adrian, Peter V ^a   Madhi, Shabir A ^a,b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

2+1; Carriage; Colonization; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE;

ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; NOSE SMEAR; PRIORITY JOURNAL; SEROTYPE; SOUTH AFRICAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; FEMALE; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MALE; MICROBIOLOGY; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROSPECTIVE STUDY; SEROTYPING; SOUTH AFRICA; TIME;

CARRIER STATE; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SEROTYPING; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 84921289171     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.12.023     Document Type: Article

References (34)

1. Smith T., Lehmann D., Montgomery J., Gratten M., Riley I.D., Alpers M.P., et al. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993, 111:27-39.
2. Sleeman K.L., Daniels L., Gardiner M., Griffiths D., Deeks J.J., Dagan R., et al. Acquisition of Streptococcus pneumoniae and nonspecific morbidity in infants and their families: a cohort study. Pediatr Infect Dis J 2005, 24:121-127.
3. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142:923-933.
4. Pneumococcal Carriage C, Kllyhty H., Auranen K., Dagan R., Goldblatt D., O'Brien K., et al. Case for carriage. Vaccine 2013, 32:180-203.
5. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007, 196:1211-1220.
6. Auranen K., Rinta-Kokko H., Goldblatt D., Nohynek H., O'Brien K.L., Satzke C., et al. Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine 2013, 32:153-158.
7. Dagan R., Givon-Lavi N., Zamir O., Sikuler-Cohen M., Guy L., Janco J., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 2002, 185:927-936.
8. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999, 180:1171-1176.
9. Loo J.D., Conklin L., Fleming-Dutra K.E., Knoll M.D., Park D.E., Kirk J., et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J 2014, 33(Suppl. 2):S161-S171.
10. Fleming-Dutra K.E., Conklin L., Loo J.D., Knoll M.D., Park D.E., Kirk J., et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage. Pediatr Infect Dis J 2014, 33(Suppl. 2):S152-S160.
11. Conklin L., Loo J.D., Kirk J., Fleming-Dutra K.E., Deloria Knoll M., Park D.E., et al. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J 2014, 33(Suppl. 2):S109-S118.
12. Dagan R., Givon-Lavi N., Porat N., Greenberg D. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine 2012, 30:5132-5140.
13. van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. J Am Med Assoc 2009, 302:159-167.
14. Madhi S.A., Bamford L., Ngcobo N. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme. S Afr Med J 2014, 104:228-234.
15. Jones S.A., Groome M., Koen A., Van Niekerk N., Sewraj P., Kuwanda L., et al. Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLOS ONE 2013, 8:e72794.
16. Madhi S.A., Adrian P., Kuwanda L., Cutland C., Albrich W.C., Klugman K.P. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae - and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization - in HIV-infected and HIV-uninfected children. J Infect Dis 2007, 196:1662-1666.
17. Nunes M.C., Shiri T., van Niekerk N., Cutland C.L., Groome M.J., Koen A., et al. Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naive South African children and their mothers. Pediatr Infect Dis J 2013, 32:e192-e205.
18. Madhi S.A., Adrian P., Cotton M.F., McIntyre J.A., Jean-Philippe P., Meadows S., et al. Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis 2010, 202:355-361.
19. Park I.H., Pritchard D.G., Cartee R., Brandao A., Brandileone M.C., Nahm M.H. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007, 45:1225-1233.
20. Nzenze S.A., Shiri T., Nunes M.C., Klugman K.P., Kahn K., Twine R., et al. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J 2013, 32:1270-1278.
21. Park I.H., Moore M.R., Treanor J.J., Pelton S.I., Pilishvili T., Beall B., et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 2008, 198:1818-1822.
22. Millar E.V., O'Brien K.L., Bronsdon M.A., Madore D., Hackell J.G., Reid R., et al. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 2007, 44:1173-1179.
23. Roca A., Hill P.C., Townend J., Egere U., Antonio M., Bojang A., et al. Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med 2011, 8:e1001107.
24. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-e11.
25. van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Keijzers W.C., Bogaert D., et al. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. J Am Med Assoc 2010, 304:1099-1106.
26. Russell C.D. Streptococcus vaccination and MRSA. Lancet Infect Dis 2012, 12:586.
27. Stamboulidis K., Chatzaki D., Poulakou G., Ioannidou S., Lebessi E., Katsarolis I., et al. The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 2011, 30:551-555.
28. Kwambana B.A., Barer M.R., Bottomley C., Adegbola R.A., Antonio M. Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants. BMC Infect Dis 2011, 11:175.
29. van Gils E.J., Hak E., Veenhoven R.H., Rodenburg G.D., Bogaert D., Bruin J.P., et al. Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS ONE 2011, 6:e20229.
30. Shiri T., Nunes M.C., Adrian P.V., Van Niekerk N., Klugman K.P., Madhi S.A. Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus colonization within and between pneumococcal-vaccine naive mother-child dyads. BMC Infect Dis 2013, 13:483.
31. Dukers-Muijrers N.H., Stobberingh E., Beisser P., Boesten R.C., Jacobs P., Hoebe C.J. Nasal carriage of Streptococcus pneumoniae serotypes and Staphylococcus aureus in Streptococcus pneumoniae-vaccinated and non-vaccinated young children. Epidemiol Infect 2013, 141:631-638.
32. Lee G.M., Huang S.S., Rifas-Shiman S.L., Hinrichsen V.L., Pelton S.I., Kleinman K., et al. Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis 2009, 9:110.
33. O'Brien K.L., Goldblatt D., Whitney C.G. Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?. Pediatr Infect Dis J 2014, 33(Suppl. 2):S107-S108.
34. von Gottberg A., de Gouveia L., Tempia S., Quan V., Meiring S., von Mollendorf C., et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 2014, 371:1889-1899.